Artificial Intelligence Satisfaction in Professionals and Patients (sAItisfACES)

February 25, 2026 updated by: Raúl Ferrer-Peña, Universidad Autonoma de Madrid

sAItisfACES - Impact of an Artificial Intelligence Tool on the Satisfaction of Professionals and Patients in Ambulatory Consultations: A Randomized Cluster Study

This multicenter cluster-randomized study evaluates the impact of an artificial intelligence (AI) tool on the satisfaction of healthcare professionals and patients in outpatient consultations, measuring its effect on perceived satisfaction (through a visual analog scale), the duration of consultations, and the quality and quantity of clinical data recorded. Adult patients (18-80 years) seen in outpatient centers will participate, comparing those using the AI tool with centers following the usual procedure. The tool is expected to reduce the administrative burden, improve user satisfaction and increase the efficiency and quality of the clinical registry. Recruitment will take place between December 2024 and May 2025, with final analysis planned for the end of 2025.

Study Overview

Status

Recruiting

Detailed Description

This multicenter cluster-randomized study aims to evaluate the impact of an artificial intelligence (AI) tool designed to optimize real-time clinical registration during outpatient consultations. Its effect on patient and healthcare professional satisfaction will be analyzed, measured using a visual analog scale (VAS) and validated tools such as the Patient Experience Questionnaire (PEQ) and the Net Promoter Score (NPS). In addition, the duration of consultations and the quantity and quality of clinical data recorded in the intervention and control groups will be compared. The intervention group will use the AI tool, while the control group will continue with the usual recording without AI. Participants will be adult patients (18-80 years) seen in health centers linked to the study, recruited by prior informed consent. AI is expected to reduce the administrative burden on professionals, allowing them to devote more time to direct care, improving both the quality of the clinical record and the patient experience. Recruitment will take place between December 2024 and May 2025, and will follow the ethical guidelines set out in the Declaration of Helsinki. This project seeks to provide evidence on the implementation of AI-based technologies in the outpatient setting and their impact on the quality of healthcare.

Study Type

Interventional

Enrollment (Estimated)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Catalonia
      • Barcelona, Catalonia, Spain, 28500
    • Madrid
      • Madrid, Madrid, Spain, 28018

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients between 18 and 80 years of age.
  • Patients consulting for any health reason in the outpatient clinics of the centers participating in the study.
  • Patients who sign the informed consent to participate in the study.

Exclusion Criteria:

  • Patients who are unable to understand or complete the questionnaires, due to:
  • Language barriers.
  • Cognitive disabilities.
  • Any other reason that prevents their adequate participation.
  • Patients who are currently participating in other clinical trials or research studies that may interfere with the results of this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Artificial Intelligence Tool
The health centers assigned to this group will implement an artificial intelligence (AI) tool for clinical registration during outpatient consultations. Healthcare professionals will activate the tool at the beginning of the consultation and deactivate it at the end. The tool will be used to document interactions in real time, generating more detailed records and reducing the administrative burden.
The intervention in this study consists of the implementation of an artificial intelligence tool for clinical registration during outpatient consultations. This technology facilitates the documentation of interactions in real time, optimizing the workflow of professionals and enabling more patient-centered care.
No Intervention: Standard of care
In the centers assigned to this group, consultations will be carried out in the usual way, using traditional clinical recording methods, without additional technological intervention. This group will serve as a reference to compare differences in satisfaction, duration of consultations and quality of the clinical record.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction with the consultation
Time Frame: From enrrolment to the end of the consultation the same day.
measured using a 10 cm Visual Analog Scale (VAS) of satisfaction, which assesses the degree of satisfaction perceived by patients and health professionals. From no satisfaction in the left side to Completely satisfied in the right side.
From enrrolment to the end of the consultation the same day.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of the consultation
Time Frame: From enrrolment to the end of the consultation the same day.
Total time of the consultation, measured manually from the time of entry to the time of departure of the patient.
From enrrolment to the end of the consultation the same day.
Number of clinical data recorded
Time Frame: From enrrolment to the end of the consultation the same day.
Total number of words documented in the clinical history generated during the consultation, excluding headings
From enrrolment to the end of the consultation the same day.
Patient Experience (Patient Expectation Questionnaire - PEQ)
Time Frame: at the begining and at the end of the consultation
Assessment of selected domains of the Patient Expectation Questionnaire (Health Service Process and Professional-Patient Communication). Format: 5-point Likert scale.
at the begining and at the end of the consultation
Likelihood of recommendation (Net Promoter Score - NPS)
Time Frame: From enrrolment to the end of the consultation the same day.
Patient's assessment of the likelihood of recommending the service received. Range: 0 (very unlikely) to 10 (very likely).
From enrrolment to the end of the consultation the same day.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemographic variables
Time Frame: at the begining of the consultation, Just after enrrollment.
Age (years)
at the begining of the consultation, Just after enrrollment.
Sociodemographic variables
Time Frame: at the begining of the consultation, Just after enrrollment.
Sex (Male/Female)
at the begining of the consultation, Just after enrrollment.
Sociodemographic variables
Time Frame: at the begining of the consultation, Just after enrrollment.
Nationality (Spanish/Other).
at the begining of the consultation, Just after enrrollment.
Sociodemographic variables
Time Frame: at the begining of the consultation, Just after enrrollment.
Municipality of residence (Rural/Non-rural).
at the begining of the consultation, Just after enrrollment.
Sociodemographic variables
Time Frame: at the begining of the consultation, Just after enrrollment.
Marital status (Single, Married, Divorced, Widowed).
at the begining of the consultation, Just after enrrollment.
Sociodemographic variables
Time Frame: at the begining of the consultation, Just after enrrollment.
Employment status (Active/Not active/Pensioner/Employed/Other).
at the begining of the consultation, Just after enrrollment.
Sociodemographic variables
Time Frame: at the begining of the consultation, Just after enrrollment.
Educational level (None, Primary, Secondary, Vocational training, University, Doctorate).
at the begining of the consultation, Just after enrrollment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Raul Ferrer, PhD, Senior Lecturer and Investigator

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2024

Primary Completion (Actual)

June 30, 2025

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

November 26, 2024

First Submitted That Met QC Criteria

December 9, 2024

First Posted (Actual)

December 10, 2024

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 25, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The study data will not be shared to ensure the confidentiality and privacy of the participants, in accordance with current regulations such as the General Data Protection Regulation (GDPR). In addition, sensitive health-related data are handled, the disclosure of which could compromise the privacy of individuals. Although the data will be anonymized, the team has decided to limit its access to authorized personnel only in order to protect the integrity of the study and minimize ethical or legal risks associated with the distribution of personal information.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on General Health Status

Clinical Trials on Artificial Intelligence Tool

Subscribe